Cardiology and Oncology Poised to Boost Single-Photon Emission Computed Tomography (SPECT) Market by 2027 End, Global Sales to Surge at Single-digit CAGR

Inadequate supply of molecular isotopes will reportedly play a key role in restraining the growth of global single-photon emission computed tomography market through to 2027. Over the assessment period 2017-2027, the SPECT market will also be affected due to lacking skilled and trained specialists and professionals in this domain.

While devices used in diagnostic imaging demand molecular isotopes, their inadequacy and lack of supply will remain a major challenge to the global SPECT market growth. Moreover, the reactors supplying molecular isotopes in Canada were recently shut down on a permanent basis due to some safety issues, further limiting the molecular isotopes supply.

Another major factor responsible to pose a negative impact on the growth of SPECT market globally, includes product recalls. With growing prevalence of cancers, CVDs, brain or other organ dysfunction, and similar conditions, SPECT devices are critically required for diagnosis, staging, restaging, and follow-ups. However, SPECT devices are often associated with adverse effects, which are followed by product recalls, consequently leading to ceasing availability, consumption, and sales.

Unsophisticated healthcare infrastructure in emerging economies and a few countries in Eastern Europe will continue to restrict the growth of SPECT market over the forecast period. In addition, insufficient funds exclusively for advanced healthcare will also represent a key factor to hold a major negative impact on market growth.

For high-quality imaging and accurate information delivery in case of an organ dysfunction, a majority imaging and diagnostic devices employ radioisotope tracers. However, such tracers have a half-life as short as six months, which strongly restrict their widespread adoption.

Key applications of SPECT, SPECT-CT, and SPECT-MRI imaging devices

Single photon emission computed tomography is an efficient nuclear medicine technique that aids non-invasive diagnostic imaging of a metabolic process. It uses radio isotopes in order to potentially generate 3D images of all metabolic processes inside a human body. Among various application areas of SPECT scanners, detection of chronic diseases is the top one globally.

Cardiology

Cardiology is a relatively more mature application area within the global SPECT market. The extent of a cardiovascular disorder and possibility of an ischemic heart disease can be recognized through a SPECT device. Moreover, it can identify patients who may potentially benefit from a heart bypass surgery.

Oncology

SPECT imaging technique plays a crucial role in staging and restaging of malignant tumors. When it comes to locating the accurate site of a suspected tumor and identifying the best site to operate it, SPECT devices are considered ideal.

Cardiology and oncology will remain the most lucrative segments based on application areas, with a market attractiveness index of 1.4.

Neurology

In diagnosis, treatment planning, and prediction of possible outcomes in case of a neurological disease, SPECT devices play a key role with the help of chemotherapy or radiation therapy or both. The effects of therapy are monitored. In terms of application, neurology segment is expected to thrive faster at a healthy CAGR of 7.9% over 2017-2027.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5826

Sabyasachi

Sabyasachi Ghosh is an experienced market research analyst and consultant, with over six years of experience in end-to-end project management. He has worked at numerous leadership positions and has a vast experience of compiling high-quality market research reports. Sabyasachi is an authoritative voice in the market research sector, and has been cited in top industry publications. He is a travel junkie, and loves to travel far and wide with his friends.